Release date: 2024-08-19 15:38:51 Article From: Lucius Laos Recommended: 130
In May 2020, Selpercatinib received FDA approval as a breakthrough drug for the treatment of RET gene fusion and mutant cancers. It is especially suitable for adult and pediatric patients with non-small cell lung cancer, medullary thyroid cancer, and advanced thyroid cancer. Selpercatinib significantly slows tumor progression by inhibiting the activity of RET kinase.
Before taking Selpercatinib, it is important to understand the relevant medication precautions.
Selpercatinib should be discontinued for at least 7 days before planned surgery. Wait at least 2 weeks after major surgery and until the wound is completely healed. There are no clear data on whether it is safe to resume medication after wound healing.
If an allergic reaction occurs, the drug should be discontinued immediately and treated with corticosteroids. Once symptoms have resolved, a lower dose can be tried to resume the medication and gradually increase to the previous dose. If the allergic reaction recurs, permanent discontinuation of the drug should be considered.
The use of medications may vary for different populations, and the following are some precautions for special populations.
For patients with mild to severe renal insufficiency, there is usually no need to adjust the dose of Selpercatinib. However, these patients should be monitored regularly for renal function to ensure that the drug does not place an additional burden on the kidneys. If changes in renal function are present, treatment should be tailored to the specific situation.
Older patients usually do not have specific clinical problems with Selpercatinib, but age may affect drug metabolism and excretion, and special attention should be paid to treatment. Treatment is carried out under the guidance of a doctor, and the dosage is adjusted according to the physical condition of the elderly patient.
Some of the side effects that may occur with the use of this drug are described below, and patients are asked to be aware of and monitor these symptoms.
Some patients may experience changes in taste that affect appetite. You can try different flavors of food or add seasonings to improve the eating experience.
Nausea and vomiting are common side effects that can affect quality of life when severe. Doctors usually prescribe anti-nausea medications and recommend eating small, frequent meals and avoiding greasy foods.
[Warm tips] Maintaining a balanced diet and adequate water intake, choosing nutritious foods, and avoiding greasy and irritating foods can help reduce side effects.
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended:2012024-09-07
On November 14, 2024, the Committee for Medicinal Products for Human Use (CHMP) of the European Medi···【more】
Recommended:1582025-13-01
Recent advancements have reaffirmed the significance of liquid biopsy in the management of advanced ···【more】
Recommended:1562025-06-01
FDA Approves First Generic Version of Victoza (liraglutide injection)The U.S. Food and Drug Administ···【more】
Recommended:1712024-30-12
The new indication involves the treatment of adult patients with locally advanced, unresectable non-···【more】
Recommended:1612024-24-12
he U.S. Food and Drug Administration (FDA) has approved Crenessity (crinecerfont) for use in combina···【more】
Recommended:1462024-17-12
In the phase Ib/II multicenter pivotal FELIX study, the autologous 41BB-ζ anti-CD19 chimeric antigen···【more】
Recommended:1052024-13-12
On 25 July 2024, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHM···【more】
Recommended:2482024-26-08
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp: